According to the results of genetic testing, 35 patients (excluding the three patients carrying multiple different gene mutations) carrying one germline mutation in an FA gene (except BRCA1/2, PALB2 and RAD51C) were included in the mutation group, and 1,133 patients who did not carry any mutations in BC susceptibility genes were the control group. Here, FANCA is linked to breast cancer.